RT Journal Article
SR Electronic
T1 Comparative Effectiveness Study of Home-Based Interventions to Prevent CA-MRSA Infection Recurrence
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.15.20154393
DO 10.1101/2020.07.15.20154393
A1 Jonathan N. Tobin
A1 Suzanne Hower
A1 Brianna M. D’Orazio
A1 María Pardos de la Gándara
A1 Teresa H. Evering
A1 Chamanara Khalida
A1 Rhonda G. Kost
A1 Kimberly S. Vasquez
A1 Hermínia de Lencastre
A1 Alexander Tomasz
A1 Barry S. Coller
A1 Roger Vaughan
YR 2020
UL http://medrxiv.org/content/early/2020/10/12/2020.07.15.20154393.abstract
AB BACKGROUND Recurrent skin and soft tissue infections (SSTI) caused by Community-Associated Methicillin-Resistant (CA-MRSA) or Methicillin-Sensitive Staphylococcus aureus (CA-MSSA) present treatment challenges.OBJECTIVES Can an evidence-based intervention (CDC Guidelines, topical decolonization, surface decontamination) reduce SSTI recurrence, mitigate household contamination and transmission, and improve patient-reported outcomes?DESIGN Randomized trialSETTING Community settingsPARTICIPANTS Participants (n=186) with confirmed MRSA(+)/MSSA(+) SSTIs and household members.INTERVENTION Community Health Workers/Promotoras conducted home visits and provided participants with instructions, a five-day supply of mupirocin for nasal application, chlorhexidine for body cleansing, and disinfecting wipes for household cleaning (EXP) versus Usual Care (UC).MEASUREMENTS Primary outcome was six-month SSTI recurrence recorded in electronic health records (EHR). Home visits (months 0/3) and telephone assessments (months 0/1/6) collected self-report data. Surveillance culture swabs (nares, axilla, groin) were obtained from index patients and participating household members. Secondary outcomes included household surface contamination, household member colonization and transmission, quality of life and satisfaction with care.RESULTS Among patients with SSTIs (n=421), 44.2% were MRSA(+)/MSSA(+); an intent-to-treat analyses (n=186) demonstrated no significant differences in SSTI recurrence (OR: 1.4, 95% CI: 0.51-3.5). Among the enrolled cohort (n=119), there were no significant SSTI recurrence effects (OR=1.14, 95% CI=0.35-3.6). EXP participants showed reduced but non-significant colonization rates. There were no differential reductions in household member transmission or in reductions in proportions of households with ≥1 contaminated surface. Mupirocin resistance did not increase. No significant improvements for patient-reported outcomes were seen.LIMITATIONS A lower-than-predicted six-month recurrence rate may have limited the ability to detect effects.CONCLUSION This intervention did not reduce clinician-reported MRSA/MSSA SSTI recurrence. No differences were observed for household members decolonization or household surfaces decontamination.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02566928Funding StatementFUNDING SOURCE: PCORI Contract Number CER-1402-10800Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Clinical Directors Network IRB and The Rockefeller University IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available following permission from the authors after publication.